Bexagliflozin

Q2 Medicine

Clinical Diabetes Pub Date : 2023-10-26 DOI:10.2337/cd23-0085

Megan Giruzzi, Ashley Worthey

{"title":"Bexagliflozin","authors":"Megan Giruzzi, Ashley Worthey","doi":"10.2337/cd23-0085","DOIUrl":null,"url":null,"abstract":"Clinical Pharmacology Update| October 26 2023 Bexagliflozin Megan Giruzzi; Megan Giruzzi 1Washington State University, College of Pharmacy and Pharmaceutical Sciences, Spokane, WA Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Search for other works by this author on: This Site PubMed Google Scholar Ashley Worthey Ashley Worthey 2MultiCare Yakima Memorial Hospital, Yakima, WA Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Clin Diabetes cd230085 https://doi.org/10.2337/cd23-0085 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Citation Megan Giruzzi, Ashley Worthey; Bexagliflozin. Clin Diabetes 2023; cd230085. https://doi.org/10.2337/cd23-0085 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search This content is only available via PDF. ©2023 by the American Diabetes Association2023Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. Article PDF first page preview Close Modal You do not currently have access to this content.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"48 12","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd23-0085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Clinical Pharmacology Update| October 26 2023 Bexagliflozin Megan Giruzzi; Megan Giruzzi 1Washington State University, College of Pharmacy and Pharmaceutical Sciences, Spokane, WA Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Search for other works by this author on: This Site PubMed Google Scholar Ashley Worthey Ashley Worthey 2MultiCare Yakima Memorial Hospital, Yakima, WA Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Clin Diabetes cd230085 https://doi.org/10.2337/cd23-0085 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Citation Megan Giruzzi, Ashley Worthey; Bexagliflozin. Clin Diabetes 2023; cd230085. https://doi.org/10.2337/cd23-0085 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search This content is only available via PDF. ©2023 by the American Diabetes Association2023Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. Article PDF first page preview Close Modal You do not currently have access to this content.

查看原文本刊更多论文

贝沙格列净

Bexagliflozin临床药理学更新| 2023年10月26日Megan Giruzzi 1华盛顿州立大学，药学和制药科学学院，华盛顿州斯波坎通讯作者:Megan Giruzzi, megan.giruzzi@wsu.edu在本网站搜索作者的其他作品PubMed谷歌学者Ashley Worthey Ashley Worthey 2MultiCare亚基马纪念医院，华盛顿州亚基马搜索作者的其他作品在本网站搜索作者PubMed谷歌学者通讯作者:Megan Giruzzi, megan.giruzzi@wsu.edu临床糖尿病cd230085 https://doi.org/10.2337/cd23-0085查看图标查看文章内容图表和表格视频音频补充数据同行评议分享图标分享Facebook Twitter LinkedIn电子邮件引用图标引用获得许可引用Megan Giruzzi, Ashley Worthey;Bexagliflozin。临床糖尿病2023;cd230085。https://doi.org/10.2337/cd23-0085下载引文文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议过滤您的搜索所有内容所有期刊临床糖尿病搜索高级搜索此内容仅通过PDF提供。©2023 by美国糖尿病协会2023读者可以使用这篇文章，只要文章被正确引用，使用是为了教育目的而不是为了盈利，并且没有改变作品。更多信息请访问https://www.diabetesjournals.org/journals/pages/license。文章PDF第一页预览关闭模式您目前没有访问此内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes Medicine-Internal Medicine

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.